Health officials in Robert F. Kennedy Jr.'s administration reportedly explored the possibility of banning some commonly prescribed antidepressant medications, according to sources familiar with the discussions.

The deliberations come amid broader concerns about maternal mental health care in the United States, an area that continues to draw attention from medical professionals and policymakers. Healthcare experts have highlighted ongoing challenges women face in accessing adequate mental health support during pregnancy and postpartum periods.

Dr. Kemi Doll, a gynecologic oncologist, has been among the medical professionals discussing the current state of maternal health conditions in the country. The intersection of mental health treatment and maternal care represents a complex policy area where medication decisions can have significant implications for patient care.

Antidepressants are among the most widely prescribed medications in the United States, with millions of Americans relying on these treatments for various mental health conditions. Any potential restrictions on these medications would likely face scrutiny from medical professionals who argue about the importance of maintaining treatment options for patients with depression and related conditions.

The reported discussions highlight the ongoing debate over pharmaceutical regulation and mental health treatment approaches within current health policy circles.